Medical cannabis: aligning use to evidence-based medicine approach
- PMID: 29859014
- PMCID: PMC6177696
- DOI: 10.1111/bcp.13657
Medical cannabis: aligning use to evidence-based medicine approach
Abstract
During the past decade we have been witnessing a rise in medical cannabis use, yet the evidence for the safety and efficacy of the various cannabinoid compounds is scarce. The State of Israel has always been at the forefront of clinical and translational research in support of Evidence Based Medicine. With respect to cannabis Israel has created a medical and regulatory environment that enables clinical studies with cannabis which may lead to improved Evidence Based use of these compounds. This opinion paper discusses selected studies into the safety and effects of cannabis derived products.
© 2018 The British Pharmacological Society.
Figures
References
-
- Gartner Inc . Gartner Hype Cycle [online]. Available at https://www.gartner.com/technology/research/methodologies/hype-cycle.jsp (last accessed 20 March 2018).
-
- Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al Cannabinoids for medical use. JAMA 2015; 313: 2456–2473. - PubMed
-
- Malik Z, Bayman L, Valestin J, Rizvi‐Toner A, Hashmi S, Schey R. Dronabinol increases pain threshold in patients with functional chest pain: a pilot double‐blind placebo‐controlled trial. Dis Esophagus 2017; 30: 1–8. - PubMed
-
- Ware MA, Wang T, Shapiro S, Collet J‐P, Boulanger A, Esdaile JM, et al Cannabis for the management of pain: assessment of safety study (COMPASS). J Pain 2015; 16: 1233–1242. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
